It starts with something small—a sore back after the weekend, a lingering shoulder issue, a knee that “just needs time.” Many patients choose to wait, expecting symptoms to resolve on their own. Too often, that delay sets off a much larger and more complex healthcare journey.

Early musculoskeletal (MSK) care functions as a powerful access strategy by interrupting the cascade of delayed care. When patients wait for back pain, shoulder issues, or knee problems to “resolve on their own,” many progress to chronic pain, reduced function, and secondary complications. Patients delay care for many reasons—uncertainty about where to go, concerns about cost, or the assumption that rest alone will be enough.

As symptoms persist or worsen, this drives higher downstream utilization: repeated ER visits, advanced imaging, specialist referrals, injections, surgeries, and long-term opioid use.

Conversely, timely conservative care—physical therapy, targeted exercise, manual therapy, and education—resolves most acute MSK episodes before they become costly chronic conditions. Studies show early intervention can reduce total MSK costs by roughly 30–50% in certain populations—with consistent reductions in surgery rates, imaging, and lost workdays.  Just as importantly, patients maintain mobility, stay active, and avoid the frustration and disruption that come with prolonged recovery.

In practice, this means making it easy for patients to access MSK expertise early—whether through direct entry to physical therapy, rapid evaluation by a musculoskeletal specialist, or guided care pathways that prioritize conservative treatment first.

By expanding access to high-quality early musculoskeletal providers, health systems relieve pressure on primary care and specialty queues, improve outcomes, and create capacity for patients who truly need advanced care. When systems rethink MSK care as an entry point—not a downstream service—they unlock capacity across the entire continuum of care.